Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Yung

Showing results (41-50 of 217) with videos related to

Pageof 22
Sort By:
Biochemical and Biophysical Research Communications|March 22, 2002
Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter regionXiaoyang Sheng, Dimpy Koul, Juinn-Lin Liu, et al.
Genome Research|November 8, 2002
Novel PAX6 binding sites in the human genome and the role of repetitive elements in the evolution of gene regulationYi-Hong Zhou, Jessica B Zheng, Xun Gu, et al.
Neuro-Oncology|October 11, 2005
Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variablesYi-Hong Zhou, Kenneth R Hess, Longjian Liu, et al.
Cancer Research|December 20, 2007
Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoterMarta M Alonso, Candelaria Gomez-Manzano, B Nebiyou Bekele, et al.
Molecular Cell|January 25, 2007
c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosisYan Xia, Ji Wang, Ta-Jen Liu, et al.
Journal of Neuro-Oncology|March 5, 2008
Knockdown of GluR1 expression by RNA interference inhibits glioma proliferationJohn F de Groot, Yuji Piao, Li Lu, et al.
International Journal of Oncology|August 9, 2002
MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancerDimpy Koul, Ruijun Shen, Anil Garyali, et al.
Neuro-Oncology|June 10, 2011
Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapySu Guan, Ruijun Shen, Tiffany Lafortune, et al.
Neuro-Oncology|May 24, 2012
Current clinical development of PI3K pathway inhibitors in glioblastomaPatrick Y Wen, Eudocia Q Lee, David A Reardon, et al.
Neuro-Oncology|July 29, 2004
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiformeSiew-Ju See, Victor A Levin, W-K Alfred Yung, et al.
Pageof 22

Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
Biochemical and Biophysical Research Communications|March 22, 2002
Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter regionXiaoyang Sheng, Dimpy Koul, Juinn-Lin Liu, et al.
Genome Research|November 8, 2002
Novel PAX6 binding sites in the human genome and the role of repetitive elements in the evolution of gene regulationYi-Hong Zhou, Jessica B Zheng, Xun Gu, et al.
Neuro-Oncology|October 11, 2005
Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variablesYi-Hong Zhou, Kenneth R Hess, Longjian Liu, et al.
Cancer Research|December 20, 2007
Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoterMarta M Alonso, Candelaria Gomez-Manzano, B Nebiyou Bekele, et al.
Molecular Cell|January 25, 2007
c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosisYan Xia, Ji Wang, Ta-Jen Liu, et al.
Journal of Neuro-Oncology|March 5, 2008
Knockdown of GluR1 expression by RNA interference inhibits glioma proliferationJohn F de Groot, Yuji Piao, Li Lu, et al.
International Journal of Oncology|August 9, 2002
MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancerDimpy Koul, Ruijun Shen, Anil Garyali, et al.
Neuro-Oncology|June 10, 2011
Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapySu Guan, Ruijun Shen, Tiffany Lafortune, et al.
Neuro-Oncology|May 24, 2012
Current clinical development of PI3K pathway inhibitors in glioblastomaPatrick Y Wen, Eudocia Q Lee, David A Reardon, et al.
Neuro-Oncology|July 29, 2004
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiformeSiew-Ju See, Victor A Levin, W-K Alfred Yung, et al.
Pageof 22